Home
News
News archive
Diamond Information


home > news Pfizer and BioNTech begin clinical trial for Omicron-specific vaccine

Pfizer and BioNTech begin clinical trial for Omicron-specific vaccine




Pfizer and BioNTech have begun a clinical trial for their Omicron-specific Covid-19 vaccine candidate, they announced in a news release on Tuesday.



Click Here to read the entire article...



Find this article in Google